Below are the most recent publications written about "Rheumatic Diseases" by people in Profiles.
-
Koumpouras F, Caricchio R. Cellular therapies for rheumatic disease. Curr Opin Rheumatol. 2026 May 01; 38(3):155-162.
-
Lenert A, Thomason J, Smith MH, Abodeely H, Hong SD, Kremer CE, Lenert PS, Sato TS, Hansmann S, Oliver M, Zhao YD, Templin J, Vaughan-Sarrazin M, Domsic R, Solomon DH, Ferguson PJ. Quality of Life in Adult Patients With SAPHO Syndrome and Chronic Nonbacterial Osteomyelitis, and Comparison to Chronic Rheumatic and Inflammatory Diseases. J Rheumatol. 2025 Oct 01; 52(10):1034-1042.
-
Kwon S, Han KD, Jung JH, Cho EB, Park J, Eun Y, Kim H, Chung YH, Shin DW, Min JH. Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea. Mayo Clin Proc. 2025 May; 100(5):801-813.
-
Winthrop KL, Bathon J, Kerschbaumer A, Isaacs JD, Mease P, Gottenberg JE, Crow MK, Kay J, Crofford L, Baraliakos X, Bykerk V, Siebert S, Kloppenburg M, Aletaha D, McInnes IB, Huizinga T, Voll R, Gravallese EM, Breedveld FC, van Vollenhoven R, Smolen JS. Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024. Ann Rheum Dis. 2025 Jun; 84(6):927-936.
-
Bridgewater S, Shepherd MA, Dawson J, Richards P, Silverthorne C, Ndosi M, Almeida C, Black RJ, Cheah JTL, Dures E, Ghosh N, Hoon EA, Lyne S, Navarro-Millan I, Pearce-Fisher D, Ruediger C, Tieu J, Yip K, Mackie SL, Goodman S, Hill C, Robson JC. Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure. Rheumatology (Oxford). 2023 11 02; 62(11):3565-3575.
-
Reginato AM, Petri MA, Kay J. Walter Bauer, Marian Wilkins Ropes, and the Massachusetts General Hospital. Rheum Dis Clin North Am. 2024 02; 50(1):79-92.
-
Wasserman I, Chari DA, Gray ST, Naunheim MR, Miloslavsky EM. Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases: Otologic, Sinus, and Airway. Rheum Dis Clin North Am. 2023 08; 49(3):633-645.
-
Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL, Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023 03; 75(3):449-464.
-
Battisha A, Sawalha K, Altibi AM, Madoukh B, Al-Akchar M, Patel B. Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes. Heart Fail Rev. 2022 01; 27(1):93-101.
-
Al-Akchar M, Sawalha K, Al-Khadra Y, Kittleson M, Missula V, Sundararajan T, Koester C, Salih M, Bhattarai M, Ibrahim A, Chami Y, DeMartini T, Hafiz AM. Outcomes of Cardiogenic Shock With Autoimmune Rheumatological Disorders. Cardiovasc Revasc Med. 2022 05; 38:70-74.